Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorLARREY, D.
dc.contributor.authorMEUNIER, L.
dc.contributor.authorPAGEAUX, G. P.
dc.contributor.authorMALEYRAN, S.
dc.contributor.authorMICON, S.
dc.contributor.authorLORRAIN, S.
dc.contributor.authorLASSALLE, R.
dc.contributor.authorDROZU-BORDEAUX, F. R. C.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorMOORE, Nicholas
dc.date.accessioned2020-11-30T08:24:05Z
dc.date.available2020-11-30T08:24:05Z
dc.date.issued2018-04
dc.identifier.issn0168-8278en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/21245
dc.language.isoENen_US
dc.subject.enPharmacoEpi-Drugs
dc.title.enDrug exposure and risk of Acute Liver Failure leading to registration for liver Transplantation (ALFT): Results of the SALT III study in adults in France
dc.title.alternativeJournal of Hepatologyen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/s0168-8278(18)31437-5en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
bordeaux.journalJ. Hepatol.en_US
bordeaux.pageS587-S588en_US
bordeaux.volume68en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamPharmacoEpi-Drugsen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03030377
hal.version1
hal.date.transferred2020-11-30T08:24:12Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=J.%20Hepatol.&rft.date=2018-04&rft.volume=68&rft.spage=S587-S588&rft.epage=S587-S588&rft.eissn=0168-8278&rft.issn=0168-8278&rft.au=LARREY,%20D.&MEUNIER,%20L.&PAGEAUX,%20G.%20P.&MALEYRAN,%20S.&MICON,%20S.&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée